Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Next-Generation Mass Spectrometer Industry?
The market for advanced mass spectrometers has experienced significant expansion in the past few years. Projected growth is from $3.26 billion in 2024, to a more substantial $3.60 billion in 2025, with a compound annual growth rate (CAGR) of 10.2%. This substantial increase in the historic period is due to escalating usage in pharmaceutical research, a heightened requirement for food safety examinations, the rise in environmental monitoring applications, the growth of academic proteomics studies, and an increase in government funding directed towards clinical diagnostics.
The market size for next-generation mass spectrometers is set to experience a notable surge in the coming years, expanding to a worth of $5.24 billion in 2029, representing a compound annual growth rate (CAGR) of 9.9%. The growth projected during the forecasted period is tied to factors like the escalating requirement for customized medicine, increasing usage in biotech and life sciences, higher instances of chronic illnesses necessitating molecular diagnostics, the extension of forensic and toxicology examinations, and rising regulatory mandates for contamination tests. Key trends anticipated throughout this period consist of miniaturized and mobile devices, progressive developments in software and AI for data analysis, R&D in proteomics and metabolomics, as well as the automation and amalgamation in high-volume analytical procedures.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27364&type=smp
#Which Factors Are Currently Driving The Growth Of The Next-Generation Mass Spectrometer Market?
The escalating focus on personalized medicine is forecasted to stimulate the expansion of the next-generation mass spectrometer market in the future. Personalized medicine refers to a healthcare strategy that adapts treatments and healthcare decisions to the unique genetic, environmental, and lifestyle attributes of an individual for more effective results. Because of the desire to administer more individualized treatments that enhance patient outcomes, minimize side effects, and maximize healthcare efficiency based on unique genetic and lifestyle attributes, there’s an escalating emphasis on personalized medicine. The next-generation mass spectrometer aids in the uptake of personalized medicine by delivering highly accurate and comprehensive molecular analysis, assisting in the identification of individual biomarkers, monitoring of therapeutic responses, and guidance of tailored treatment schemes for improved patient outcomes. For example, a report by the Personalized Medicine Coalition, a non-profit entity based in the US, revealed in February 2024 that the US-based federal agency, the Food and Drug Administration (FDA), approved 16 new personalized medicines for patients with rare diseases in 2023, an increase from six in 2022. Hence, the escalating focus on personalized medicine is expected to fuel the expansion of the next-generation mass spectrometer market.
How Is The Global Next-Generation Mass Spectrometer Market Structured In Terms Of Segments?
The next-generation mass spectrometer market covered in this report is segmented
1) By Type: Fourier Transform, Linear Ion Trap Mass Spectrometry, Other Types
2) By Application: Pharmaceuticals, Biotechnology, Clinical Diagnostics, Environmental Analysis, Food And Beverage Testing, Forensic Science, Other Applications
3) By End User: Research Laboratories, Academic Institutions, Pharmaceutical Companies, Biotechnology Firms, Clinical Laboratories, Government Agencies
Subsegments:
1) By Fourier Transform Mass Spectrometry: Fourier Transform Ion Cyclotron Resonance (FT-ICR), Fourier Transform Orbitrap Mass Spectrometry, Hybrid FT-MS Systems, High-Resolution Accurate Mass (HRAM) FT-MS
2) By Linear Ion Trap Mass Spectrometry: Quadrupole Ion Trap, Three-Dimensional Linear Ion Trap, Dual-Pressure Linear Ion Trap, Linear Ion Trap-Time Of Flight (LIT-TOF) Hybrid
3) By Other Types: Time-Of-Flight Mass Spectrometry (TOF-MS), Quadrupole Mass Spectrometry, Orbitrap Mass Spectrometry (Non-FT Applications), Magnetic Sector Mass Spectrometry, Ion Mobility Mass Spectrometry, Hybrid Mass Spectrometers
What Trends Are Currently Influencing Growth In The Next-Generation Mass Spectrometer Market?
Significant corporations in the next-generation mass spectrometer market are making strides towards creating highly effective tools, enabling scientists to examine complex biological samples with unmatched speed and accuracy. These advancements aim to bolster biomarker detection, promote early illness identification and hasten the creation of customized treatments. For example, US-based clinical research firm Thermo Fisher Scientific Inc. introduced the Orbitrap Astral mass spectrometer in June 2023. It’s considered one of the most substantial leaps forward in mass spectrometry in the past 15 years, offering rapid throughput, high sensitivity, and comprehensive proteome coverage. This cutting-edge tool allows scientists to uncover previously undetectable proteins of low abundance by combining ultra-quick scan speeds, extraordinary sensitivity, and extensive proteome coverage, greatly elevating large-scale proteomic studies. Furthermore, it features superior ion transmission efficiency, amplified dynamic range, and throughput up to four times faster, paving the way for quicker biomarker detection, accurate quantification, and the creation of disease-specific therapies.
Who Are The Main Participants Shaping The Next-Generation Mass Spectrometer Market Landscape?
Major companies operating in the next-generation mass spectrometer market are Hitachi Ltd., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd., JEOL Ltd., Rigaku Corporation, LECO Corporation, Hiden Analytical Ltd., Scion Instruments Ltd., MOBILion Systems Inc., Jiangsu Skyray Instrument Co. Ltd., Spacetek Technology Inc., and Hexsor Scientific Ltd.
Get The Full Report Here:
Which Region Currently Holds The Largest Share In The Next-Generation Mass Spectrometer Market?
North America was the largest region in the next-generation mass spectrometer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation mass spectrometer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27364&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model